Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 25;15(11):1316.
doi: 10.3390/ph15111316.

Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors

Xixi Hou  1 , Xiaoqing Gong  2 , Longfei Mao  1   3 , Jie Zhao  3 , Jianxue Yang  1   4
Affiliations

Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors

Xixi Hou et al. Pharmaceuticals (Basel). .

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1) has received much attention as an immunomodulatory enzyme in the field of cancer immunotherapy. While several IDO1 inhibitors have entered clinical trials, there are currently no IDO1 inhibitor drugs on the market. To explore potential IDO1 inhibitors, we designed a series of compounds with urea and 1,2,3-triazole structures. Organic synthesis and IDO1 enzymatic activity experiments verified the molecular-level activities of the designed compounds, and the IC50 value of compound 3a was 0.75 μM. Molecular docking and quantum mechanical studies further explained the binding mode and reaction potential of compound 3a with IDO1. Our research has resulted in a series of novel IDO1 inhibitors, which is beneficial to the development of drugs targeting IDO1 in numerous cancer diseases.

Keywords: 1,2,3-triazole; indoleamine 2,3-dioxygenase 1; molecular docking; quantum mechanical studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of four IDO1 inhibitors.
Figure 2
Figure 2
Pocket surface map of the crystal structure of IDO1 complexed with Amg-1 (PDB code: 4PK5). Purple represents amino acids contained in pocket A; green represents amino acids contained in pocket B.
Figure 3
Figure 3
The reaction routes to compounds 3a–3i, 5a–5f, and 7a–7f.
Figure 4
Figure 4
The binding modes of compounds 3a (A), 5e (B) and 7f (C).
Figure 5
Figure 5
Frontier molecular orbitals of compounds 3a (A), 5e (B) and 7f (C).
Figure 6
Figure 6
MEP surfaces of compound 3a.
See this image and copyright information in PMC

References

    1. Macan A.M., Harej A., Cazin I., Klobucar M., Stepanic V., Pavelic K., Pavelic S.K., Schols D., Snoeck R., Andrei G., et al. Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives. Eur. J. Med. Chem. 2019;184:111739. doi: 10.1016/j.ejmech.2019.111739. - DOI - PMC - PubMed
    1. Mao L.F., Wang Y.W., Zhao J., Xu G.Q., Yao X.J., Li Y.M. Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors. Front. Pharmacol. 2020;11:579024. doi: 10.3389/fphar.2020.579024. - DOI - PMC - PubMed
    1. Nelp M.T., Kates P.A., Hunt J.T., Newitt J.A., Balog A., Maley D., Zhu X., Abell L., Allentoff A., Borzilleri R., et al. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proc. Natl. Acad. Sci. USA. 2018;115:3249–3254. doi: 10.1073/pnas.1719190115. - DOI - PMC - PubMed
    1. Pan S., Zhou Y., Wang Q., Wang Y., Tian C., Wang T., Huang L., Nan J., Li L., Yang S. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO) Eur. J. Med. Chem. 2020;207:112703. doi: 10.1016/j.ejmech.2020.112703. - DOI - PubMed
    1. Partyka A., Chlon-Rzepa G., Wasik A., Jastrzebska-Wiesek M., Bucki A., Kolaczkowski M., Satala G., Bojarski A.J., Wesolowska A. Antidepressant- and anxiolytic-like activity of 7-phenylpiperazinylalkyl-1,3-dimethyl-purine-2,6-dione derivatives with diversified 5-HT(1)A receptor functional profile. Bioorg. Med. Chem. 2015;23:212–221. doi: 10.1016/j.bmc.2014.11.008. - DOI - PubMed